Gladstone in the News

The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.

New Gene Therapy Approach May Regenerate Heart Muscle After A Heart Attack
August 22, 2013

Heart disease, a leading cause of death in the U.S., costs billions, literally, in terms of services, medications, and lost productivity. Now, researchers have developed a new technique that “personalizes” treatment for those suffering from heart disease — a gene therapy approach that would be able to convert cells into heart muscle cells.

Scientists Make Damaged Heart Cells Healthy Again in Lab Tests
August 22, 2013

Gladstone scientists report that they've transformed one kind of human heart cell into another in laboratory experiments, a promising development in the bid to find ways to repair damage from heart attacks. 

New Gene Therapy May Help Heart Attack Survivors
August 22, 2013

Researchers from the Gladstone Institutes in San Francisco found that injecting a therapy of genes into dead heart cells has promising implications for restarting the cells, based on studies done in mice and human cells in a lab. 

Professor Helps Develop pE-MAP Technique That Allows Scientists To Predict Effect of Enzyme Mutations
August 12, 2013

A research team led by Nevan Krogan, PhD, of Gladstone Institutes and the University of California, San Francisco (UCSF); Craig Kaplan, PhD, of Texas A&M University; and Christine Guthrie, PhD, a UCSF Professor, has created a new technique called the point mutant E-MAP approach (pE-MAP) to predict how an enzyme behaves, and what happens when this process is disrupted, by mapping thousands of interactions among an enzyme’s many moving parts.

Acclaimed Molecular Biologist Named New QB3-UCSF Director
July 31, 2013

Gladstone Investigator Nevan Krogan, PhD, is named new director of the California Institute for Quantitative Biosciences (QB3).

HIV/AIDS: The Fight Isn't Over
July 25, 2013

Gladstone's Warner C. Greene, MD, PhD, explains in an op-ed why we must continue the fight against HIV/AIDS worldwide. 

The Rise of the Multi-Talented Adult Stem Cell
July 25, 2013

A new type of cell could lead to dramatic cures—and avoid ethical controversy. The Smithsonian's Virginia Hughes speaks to Gladstone stem cell scientist Dr. Deepak Srivastava.

 

Toxic Brain Protein: Risky If Not Cleared
July 23, 2013

Using a method called optical pulse-labeling (OPL), researchers from the Gladstone Institutes discovered for the first time that neurons’ inability to clear toxic proteins associated with Huntington’s disease is responsible for protein buildup, which eventually causes the neurons to wither away.

Kathy Ivey and the Great Stem Cell Research Training Grant
July 23, 2013

Seven years ago, the California stem cell research program was ready to give its very first grants. Voted into law in 2004, it had been delayed by lawsuits from the religious right and anti-tax groups for almost two years. But in 2006, Governor Schwarzenegger authorized a $150 million loan to the fledgling program. Prop 71 author Bob Klein persuaded philanthropists to help as well, and it was time.

Researchers Take More Nuanced Approach To Making Stem Cells
July 19, 2013

Researchers are building upon Shinya Yamanaka's Nobel prize-winning discovery to improve methods of creating iPS cells.